亞馬遜(AMZN.US)首次聯泡泡瑪特(09992.HK)打假 浙江當局檢逾700件翻版LABUBU玩具
近期,亞馬遜(Amazon.com,Inc.)(AMZN.US)首次聯合泡泡瑪特(09992.HK),配合浙江當地市場監管部門成功打擊了一間售假供應商。執法單位於今年4月現場查獲翻版LABUBU鑰匙掛件超700件、包裝材料上千件。
報道提及,上述供應商通過國內某電商批發網站,向亞馬遜賣家銷售翻版「LABUBU」玩具。亞馬遜全球打假團隊在中國經過數月追蹤並調查鎖定售假供應商,並將案件線索移交給此供應商所在的當地執法部門。
日前,內媒報道指,浙江多地打擊侵權LABUBU商品。近一年來,單計寧波海關累計查獲60宗侵犯泡泡瑪特知識產權案件,扣留侵權商品逾118萬件。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.